Teva wraps up $4.95B Ratiopharm buyout; Novartis wins Alcon deal OK from EU, Canada;

@FiercePharma: Sanofi deal could bring $22M bonus for Termeer. Article | Follow @FiercePharma

> Teva Pharmaceutical has solidified operations further in Europe, announcing that it completed a $4.95 billion buyout of German drugmaker Ratiopharm. Teva's release | Article

> Swiss drugmaker Novartis has received approval from EU and Canadian regulators to buy a minority stake in Alcon, making it easier for it to take full control of the U.S. eyecare group. Report

> Dr. Reddy's has launched Cresp, its new biosimilar version of the Amgen anemia drug Aranesp, in India. Dr. Reddy's release | Story

> King Pharmaceuticals' quarterly profit was cut in half as sales of its muscle-relaxant Skelaxin plunged 95 percent due to generic competition, but overall results slightly topped expectations. Item

> In a twist to the tale of drug patent infringement cases in the U.S., Indian drug company Lupin has sued Ranbaxy Laboratories in a U.S. court. News

Biotech News

  @FierceBiotech: Mayo Clinic to launch center for social media. Report | Follow @FierceBiotech

  @JohnCFierce: It's rare to see a Ph3 drug with the kind of compelling, clean profile that telaprevir has.  | Follow @JohnCFierce

> Elan, Transition push ahead with troubled Alzheimer's drug. Item

> TetraLogic nabs $32 million round for lead cancer therapy. Article

> Endo buying partner in pain Penwest for $168 million. News

> Report: China readies $1.5 billion plan to bolster biotech. Report

> Vertex's telaprevir cuts hep C treatment time in half. Story

Biotech Research News

> Gene recipe regenerates damaged heart tissue. Story

> Scientists look to newt to regenerate tissue in mice. Article

> Debate over chimps pits lawmakers against researchers. News

> Investigators create cancer-fighting T cell receptors. Item

> Lab accident opens door to new fertility treatment. Article

> Leptin fades as a prime obesity target. News

Manufacturing News

> Indian packager Bilcare looks west for expansion. Report

> Gilead SEC filing anticipates FDA warning letter. Item

> FDA to skip legal review of warning letters. News

> Distribution change affects supply chain balance of power. Article

> Private labeler Activis revs up for Tylenol shortfall. Item

> Sun enjoys fleeting profit boost from oxaliplatin. Story

And Finally... A new study suggests that a 50-year-old drug commonly used as an anesthetic for humans and animals--and abused, as the drug called Special K--may deliver almost instant relief in some of the most troublesome cases of bipolar depression. Story

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.